DGAP-News: MIG Verwaltungs AG / Key word(s): Investment
Germany's MIG Fonds makes first French investment with deep-tech company Zadient Technologies
Munich, 12 February 2021
Zadient specializes in the production of synthetic silicon carbide (SiC) a building block for power semiconductors important for the rapidly growing electric vehicle market and used in a variety of other industrial applications. SiC occurs in nature as the extremely rare mineral, moissanite. Current processing methods of synthetic SiC are highly complex and expensive. Zadient's innovation lies in its high quality crystal production which improves the manufacturing process and lowers semiconductor production costs. The first round of financing will be used to develop the technology for market entry.
MIG's involvement in Zadient follows a previous successful investment in the SiC market. In 2018, MIG sold its portfolio company Siltectra, focused on an earlier stage of the value chain, to Infineon for a significant sum. The experience allows MIG Fonds to contribute important expertise, including in the person of Dr. Jan Richter, former CTO of Siltectra, as co-founder of Zadient.
Dr. Sören Hein, Partner of MIG AG, said, "We are pleased to finance a second promising company in the exciting silicon carbide market as well as contributing our network and experience."
Zadient is MIG's first investment in France and only the fourth portfolio company of MIG Fonds outside the German-speaking region, following Innatera (Netherlands, 2020), IQM (Finland, 2019) and Liva Healthcare (Denmark, 2019).
Michael Motschmann, General Partner of MIG AG, said, "With our first French investment, we strengthen the international orientation of our portfolio and engage in one of the most dynamic European markets for innovative deep-tech start-ups."
About MIG AG
MIG's investment team consists of a dedicated expert group of engineers, biologists, scientists and investors who use analytical and creative processes to evaluate risks and opportunities of business models and technologies. Their reputation, experience and network provide excellent access to companies, institutions and decision makers to support the growth of their portfolio companies
In recent years, MIG AG realized successful sales of the portfolio companies SuppreMol (to Baxter International, 2015), sunhill technologies (Volkswagen, 2015), Ganymed (Astellas Pharma, 2016) and Siltectra (Infineon, 2018) and placed several companies on the stock exchange with BRAIN (2017), NFON (2018), BioNTech (2019) and Immatics (2020).
For further information please visit: www.mig.ag, www.mig-fonds.de
MC Services (for media inquiries)
12.02.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.